Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2023 ASCO Annual Meeting
Speaker: Ferdinandos Skoulidis, PhD
2023 ASCO Annual Meeting
Speaker: Hiroaki Akamatsu, MD, PhD
2022 ASCO Gastrointestinal Cancers Symposium
Speaker: David S. Hong, MD
2021 ASCO Annual Meeting
Speaker: Mustafa Ozguroglu, MD